Title Daily cost of glaucoma medications in China
Authors Gao, Ying
Wu, Lingling
Li, Aijun
Affiliation Peking Univ, Ctr Eye, Peking Univ Hosp 3, Beijing 100083, Peoples R China.
Keywords glaucoma
medicine
cost
OPEN-ANGLE GLAUCOMA
OCULAR HYPERTENSION
BETA-BLOCKER
LATANOPROST
THERAPY
FRANCE
Issue Date 2007
Publisher journal of glaucoma
Citation JOURNAL OF GLAUCOMA.2007,16,(7),594-597.
Abstract Purpose: To determine and compare the daily cost of various glaucoma medications in China. Materials and Methods: The majority of glaucoma medications commercially available in China were included in this research. The total number of drops in I bottle of each medication was counted drop by drop. The mean volume per bottle of each medication was calculated. The cost per drop, number of days for both eyes usage per bottle, and daily cost was calculated. Results: (1) The volume per drop ranged from 0.03mL (brinzolamide 1%, travoprost 0.004%, bimatoprost 0.03%, and latanoprost 0.005%) to 0.05mL (timolol 0.5%-Chengrui and pilocarpine 0.5% and 2%-Zhenrui). (2) The cost per bottle ranged from SO.69 (US dollar) (timolol 0.5%-Malaisuan Saimaluo'er) to S40.78 (latanoprost 0.005%). (3) The number of days for both eyes usage per bottle ranged from 52 days (bimatoprost 0.03%) to 11 days (pilocarpine nitrate 0.5%-Zhenrui). (4) The daily cost for both eyes usage from expensive to cheap were latanoprost 0.005%-S0.91, travoprost 0.004%S0.77. brimonidine 0.2%-S0.61, bimatoprost 0.03%-$0.46, D-timolol 1%-S0.36, brinzolamide 1%-S0.34, pilocarpine 2%-Zhenrui-S0.28. levobunolol 0.5%-$0.25, betaxolol 0.25%S0.24, pilocarpine 0.5%-Zhenrui-$0.18, pilocarpine 2%-Humm2-S0.16, carteolol 1%-Mikelan-S0.15, carteolol 2%-MikeIan-S0.15, pilocarpine 1%-Huming $0.10, timolol 0.5%-Chengrui-S0.08, timolol 0.5%-Malaisuan Saimaluo'er-S0.03. Conclusions: The daily cost of glaucoma medications in China ranged much more wildly than developed countries. These data may be useful in selecting medications for glaucoma therapy. The ophthalmic solution of prostaglandins is powerful in reducing intraocular pressure. However, its high price should be considered when selecting glaucoma medications in China.
URI http://hdl.handle.net/20.500.11897/345288
ISSN 1057-0829
DOI 10.1097/IJG.0b013e318064c818
Indexed SCI(E)
PubMed
Appears in Collections: 第三医院

Files in This Work
There are no files associated with this item.

Web of Science®


8

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.